Your browser is no longer supported. Please, upgrade your browser.
Settings
PLSE Pulse Biosciences, Inc. daily Stock Chart
PLSE [NASD]
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-2.17 Insider Own0.90% Shs Outstand21.27M Perf Week-3.06%
Market Cap256.09M Forward P/E- EPS next Y-2.10 Insider Trans0.00% Shs Float8.38M Perf Month2.56%
Income-39.00M PEG- EPS next Q-0.51 Inst Own9.30% Short Float27.06% Perf Quarter-33.85%
Sales- P/S- EPS this Y-26.90% Inst Trans6.57% Short Ratio42.86 Perf Half Y21.13%
Book/sh2.86 P/B4.21 EPS next Y-0.50% ROA-75.50% Target Price27.00 Perf Year-26.45%
Cash/sh2.48 P/C4.85 EPS next 5Y- ROE-82.60% 52W Range8.60 - 19.77 Perf YTD5.06%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-39.10% Beta-
Dividend %- Quick Ratio17.10 Sales past 5Y- Gross Margin- 52W Low40.00% ATR0.76
Employees54 Current Ratio17.10 Sales Q/Q- Oper. Margin- RSI (14)44.08 Volatility4.90% 6.79%
OptionableYes Debt/Eq0.00 EPS Q/Q5.30% Profit Margin- Rel Volume0.73 Prev Close11.86
ShortableYes LT Debt/Eq0.00 EarningsJul 30 AMC Payout- Avg Volume52.91K Price12.04
Recom2.00 SMA200.42% SMA50-8.91% SMA200-12.91% Volume38,868 Change1.52%
Feb-25-19Initiated H.C. Wainwright Buy $27
Jun-17-19 07:22PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
May-23-19 01:44PM  Is Pulse Biosciences's (NASDAQ:PLSE) 189% Share Price Increase Well Justified? Simply Wall St. -5.40%
May-15-19 04:27PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Apr-30-19 10:24PM  Pulse Biosciences, Inc. (PLSE) Q1 2019 Earnings Call Transcript Motley Fool -5.15%
04:34PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
Apr-17-19 07:27PM  Pulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial Results Business Wire
Apr-15-19 05:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Mar-26-19 02:57PM  Pulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual Conference Business Wire
Mar-19-19 08:00AM  Pulse Biosciences Appoints Mitchell Levinson to Board of Directors Business Wire
Mar-15-19 04:33PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Mar-01-19 08:00AM  Pulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual Meeting Business Wire +8.08%
Feb-28-19 04:00PM  Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX System Business Wire
Feb-15-19 04:31PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Feb-07-19 09:56PM  Pulse Biosciences, Inc. (PLSE) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
Jan-28-19 08:56PM  Pulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial Results Business Wire
Jan-17-19 04:39PM  Pulse Biosciences Announces Two Appointments Focused on CellFX Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson Business Wire
Jan-15-19 05:25PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Jan-07-19 08:00AM  Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face Business Wire +6.18%
Dec-25-18 10:53AM  How Many Insiders Bought Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares? Simply Wall St.
Dec-17-18 05:31PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Dec-14-18 04:35PM  Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering Business Wire
Dec-11-18 07:50AM  Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group Discovering Underlying Factors of Influence GlobeNewswire
Dec-07-18 09:11AM  Pulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights Offering Business Wire
Nov-19-18 05:14PM  Pulse Biosciences, Inc. Announces Commencement of Rights Offering Business Wire +5.46%
Nov-15-18 04:48PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire +7.00%
Nov-07-18 11:51PM  Pulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration Statement Business Wire
Nov-02-18 07:20AM  Report: Developing Opportunities within Pulse Biosciences, Baxter International, FirstEnergy, Affiliated Managers Group, Baidu, and Shopify Future Expectations, Projections Moving into 2018 GlobeNewswire
Oct-30-18 04:03PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire +13.03%
Oct-25-18 08:46AM  Pulse Biosciences Files Registration Statement for Rights Offering Business Wire +17.62%
Oct-23-18 04:05PM  Pulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial Results Business Wire
Oct-15-18 04:24PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Oct-11-18 08:00AM  Pulse Biosciences Announces Continued Expansion of Its Clinical Study Programs in Dermatology Business Wire
Oct-09-18 11:26AM  What Kind Of Risk Should You Expect For Pulse Biosciences Inc (NASDAQ:PLSE)? Simply Wall St. -5.30%
Oct-01-18 06:18PM  Pulse Biosciences to Present at the Cantor Global Healthcare Conference Business Wire
Sep-19-18 04:05PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Aug-13-18 04:01PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders Business Wire
Aug-03-18 04:50PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Jul-31-18 04:00PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
02:30PM  Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-30-18 04:55PM  Pulse Biosciences Treats Initial Patient in Its Human Study Evaluating the Effects of Nano-Pulse Stimulation in Basal Cell Carcinoma Business Wire
Jul-12-18 02:30PM  Pulse Biosciences to Report Second Quarter 2018 Financial Results and Operational Highlights Business Wire
Jul-10-18 04:00PM  Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for the Treatment of Sebaceous Hyperplasia Lesions Business Wire -5.07%
Jun-25-18 08:07PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders Business Wire -6.90%
08:00AM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Jun-20-18 08:00AM  Kaskela Law LLC Announces Investigation of Pulse Biosciences, Inc. on Behalf of Stockholders ACCESSWIRE
May-16-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire +8.74%
May-08-18 04:28PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
Apr-30-18 04:01PM  Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights Business Wire
Apr-18-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employee Business Wire
Apr-13-18 04:32PM  Why Alaska Air Group, Pulse Biosciences, and BJ's Restaurants Jumped Today Motley Fool +10.56%
08:30AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:48AM  Pulse Biosciences stock soars to lead premarket gainers after positive study results MarketWatch
Apr-12-18 05:19PM  Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting Business Wire
Mar-21-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Mar-16-18 04:00PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
09:30AM  Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
06:54AM  Is Pulse Biosciences Incs (NASDAQ:PLSE) CEO Incentives Align With Yours? Simply Wall St.
Mar-08-18 01:45PM  Pulse Biosciences to Report Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights Business Wire
Feb-20-18 07:30AM  Consolidated Research: 2018 Summary Expectations for RealPage, Briggs & Stratton, Genesis Energy, Synchrony Financial, Pulse Biosciences, and Ally Financial Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-19-17 07:10AM  Blog Exposure - Pulse Biosciences Grants Equity Inducement Awards to Its New Employees ACCESSWIRE
Dec-15-17 08:32PM  Pulse Biosciences Grants Equity Inducement Awards to New Employees Business Wire
Dec-14-17 08:05AM  Does Pulse Biosciences Incs (NASDAQ:PLSE) CEO Pay Reflect Performance? Simply Wall St.
Dec-04-17 08:05AM  New Research: Key Drivers of Growth for Synchrony Financial, Pulse Biosciences, Ally Financial, RealPage, Briggs & Stratton, and Genesis Energy Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-07-17 04:22PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
10:00AM  Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 07:10AM  Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board ACCESSWIRE +9.22%
Nov-03-17 08:00AM  Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members Business Wire
07:50AM  Detailed Research: Economic Perspectives on Discover Financial, Pulse Biosciences, The Travelers Companies, Xylem, Cheniere Energy Partners, and Cheniere Energy What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-24-17 05:00PM  Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017 Business Wire
Oct-15-17 01:37PM  Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE) Simply Wall St.
Sep-25-17 08:00AM  Pulse Biosciences Announces $30 Million Private Placement Business Wire +24.43%
Sep-11-17 03:37PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc. Business Wire -21.00%
02:20PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE) Business Wire
12:38PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE) PR Newswire
11:17AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Pulse Biosciences, Inc. Business Wire
08:00AM  Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System Business Wire
Jul-27-17 04:00PM  Pulse Biosciences Quarterly Investor and Analyst Conference Call Business Wire -7.33%
11:00AM  Investor Network: Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-11-17 07:30PM  Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017 Business Wire
Jun-06-17 08:00AM  Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions Business Wire
May-07-17 10:39PM  Edited Transcript of PLSE earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 01:30PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
10:00AM  Investor Network: Pulse Biosciences, Inc. to Host Earnings Call Accesswire
Apr-17-17 06:34PM  Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017 Business Wire
Mar-27-17 09:30AM  Xenon Pharmaceuticals Falls as Acne Drug Fails Study, Pulse Biosciences Submits 510(k) to FDA Accesswire
Mar-26-17 10:25AM  Insider Buying Jumps as Market Volatility Grows: Sears, IFF, Pulse Biosciences, PRA Group, Radius Health and More
Mar-24-17 01:04PM  PULSE BIOSCIENCES, INC. Financials
Mar-23-17 01:08PM  Insiders Load Up on Pulse Biosciences GuruFocus.com
Mar-20-17 05:17PM  PULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
Mar-14-17 04:30PM  Pulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET today
04:20PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:00PM  Pulse Biosciences Quartery Investor Conference Call Business Wire
08:30AM  Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System Business Wire
07:07AM  Q4 2016 Pulse Biosciences Inc Earnings Release - Time Not Supplied
Mar-01-17 04:46PM  Pulse Biosciences to Host Investor Conference Call on March 14, 2017 Business Wire
Feb-23-17 01:11PM  StreetSweeper's New Short: Pulse Biosciences Benzinga
Feb-22-17 05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars at bizjournals.com
05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars American City Business Journals
Feb-21-17 05:13PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.